UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000021827 |
|---|---|
| Receipt number | R000025165 |
| Scientific Title | Clinical efficacy of nab-PTX+GEM chemotherapy plus zoledronate- activated autologous killer lymphocytes (ZAK cells) in patients with unresectable or recurrent pancreas cancer |
| Date of disclosure of the study information | 2016/04/07 |
| Last modified on | 2023/04/13 12:30:05 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2016/04/07 17:57:19 | ||
| 2 | Update | 2016/04/07 17:59:22 | Recruitment status |
|
| 3 | Update | 2016/10/05 09:31:07 | Basic design Control No. of arms Interventions/Control_1 Interventions/Control_1 Interventions/Control_2 Interventions/Control_2 Interventions/Control_3 Interventions/Control_3 Interventions/Control_4 Interventions/Control_4 Interventions/Control_5 Interventions/Control_5 Target sample size |
|
| 4 | Update | 2016/10/05 09:32:10 | Date of protocol fixation Anticipated trial start date |
|
| 5 | Update | 2016/10/06 12:20:45 | Email1 |
|
| 6 | Update | 2017/12/06 19:01:25 | Public title Public title Acronym Acronym |
|
| 7 | Update | 2020/07/10 16:09:25 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Organization Organization Address Address Tel |
|
| 8 | Update | 2020/07/10 16:10:09 | Last follow-up date |
|
| 9 | Update | 2023/04/13 12:28:57 | Recruitment status Date of IRB |
|
| 10 | Update | 2023/04/13 12:30:05 | Number of participants that the trial has enrolled |
